Rheumatism drug teriflunomide shows subtype-dependent effects in breast cancer cells
A cell study finds teriflunomide suppresses growth signalling in luminal breast cancer cells while triple-negative cells show adaptive kinase rewiring.
A cell study finds teriflunomide suppresses growth signalling in luminal breast cancer cells while triple-negative cells show adaptive kinase rewiring.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine